Skip to content

Journal · Neurology · Updated 21 November 2026

Current Neurology and Neuroscience Reports

Read Current Neurology and Neuroscience Reports articles on DeepDyve. No university library needed.

Current Neurology and Neuroscience Reports has published since 2000 and publishes reviews of recent advances in neurology, from Parkinson disease and dystonia to multiple sclerosis and brain tumors. Springer Nature publishes it. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.

Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.

Personal plans aren’t for business use. Reading for work? See Enterprise.

Cover of Current Neurology and Neuroscience Reports
Journal cover

Current Neurology and Neuroscience Reports at a glance

Full title
Current Neurology and Neuroscience Reports
Abbreviation (NLM)
Curr Neurol Neurosci Rep
Publisher
Springer Nature
Print ISSN
1528-4042
Online ISSN (eISSN)
1534-6293
First published
2000
Subjects
Neurology
Access model
Hybrid (36% free to read in 2026)

Ways to access Current Neurology and Neuroscience Reports

36% of the articles Current Neurology and Neuroscience Reports published from January 1 to November 19, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.

  1. Open access articles. 36% of Current Neurology and Neuroscience Reports articles published from January 1 to November 19, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
  2. The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
  3. Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
  4. NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
  5. A library. Your university, hospital or public library may subscribe to Current Neurology and Neuroscience Reports. Check its journal list and whether it offers remote access.
  6. DeepDyve. Read Current Neurology and Neuroscience Reports articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.

Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.

Impact factor and metrics

Current Neurology and Neuroscience Reports’ 2025 Journal Impact Factor is 7.4, and its 5-year Impact Factor is 7.2.

7.4

Journal Impact Factor (2025)

7.2

5-year Impact Factor (2025)

2 days

Median time to first decision

Source: journal metrics on the Current Neurology and Neuroscience Reports homepage (Springer Nature), checked November 21, 2026. Impact Factor from Clarivate Journal Citation Reports.

Recent Current Neurology and Neuroscience Reports research worth reading

Published January to April 2026. Summaries describe what the authors report.

  1. Open accessParkinson disease · Digital health

    Digital Technologies for Symptom Monitoring in Parkinson Disease

    The authors review digital health technologies such as wearable sensors, mobile apps and radio wave trackers for monitoring Parkinson disease symptoms remotely, noting they can track subtle changes over time and that standardized methods are needed for wide use.

    Chunga et al. · Current Neurology and Neuroscience Reports, published online March 4, 2026 · DOI 10.1007/s11910-026-01481-7

  2. LitStreamParkinson disease · Neuropathology

    Amyloid and Tau Co-pathology in Parkinson Disease and Atypical Parkinsonism

    In a narrative review, Angel Pinto and colleagues report that post-mortem surveys find amyloid-β plaques uncommon in non-demented Parkinson disease (10%), intermediate in Parkinson disease dementia (30–40%) and frequent in dementia with Lewy bodies (60–80%).

    Angel Pinto et al. · Current Neurology and Neuroscience Reports, published online March 25, 2026 · DOI 10.1007/s11910-026-01488-0

  3. LitStreamCarotid plaque · Lipid-lowering therapy

    Effect of non-statin Therapy on the Composition and Characteristics of Carotid Atherosclerotic Plaques: A Systematic Review

    In a systematic review, Garagoli and colleagues report that studies suggest PCSK9 inhibitors are associated with reductions in lipid-rich necrotic core volume, intraplaque neovascularization and inflammatory activity in carotid plaques, while ezetimibe has shown neutral or inconsistent effects.

    Garagoli et al. · Current Neurology and Neuroscience Reports, published online January 31, 2026 · DOI 10.1007/s11910-025-01476-w

  4. LitStreamCerebral palsy · Genetics

    Advances in Genetic Discoveries in Cerebral Palsy: Implications for Diagnosis, Prognosis, and Counseling

    Ortigoza-Escobar reviews genetic contributions to cerebral palsy, particularly when neuroimaging is normal or progression is atypical, and notes that trio-based whole-exome sequencing is recommended as first-line testing, supported by chromosomal microarray or whole-genome sequencing.

    Ortigoza-Escobar · Current Neurology and Neuroscience Reports, published online January 3, 2026 · DOI 10.1007/s11910-025-01475-x

  5. LitStreamMultiple sclerosis · Diagnosis

    When is the Radiologically Isolated Syndrome already Multiple Sclerosis According to the 2024 McDonald Criteria?

    Van Horebeek and colleagues review the 2024 McDonald criteria, which extend a multiple sclerosis diagnosis to some people with typical MRI findings but no classic symptoms, and weigh the benefits and potential disadvantages for patients, clinical practice and society.

    Van Horebeek et al. · Current Neurology and Neuroscience Reports, published online April 24, 2026 · DOI 10.1007/s11910-026-01495-1

See every Current Neurology and Neuroscience Reports article on DeepDyve

Questions about Current Neurology and Neuroscience Reports

How can I read Current Neurology and Neuroscience Reports articles without a subscription?

36% of Current Neurology and Neuroscience Reports articles published from January 1 to November 19, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read Current Neurology and Neuroscience Reports articles online for $59 a month or $499 a year after a free first month.

What is the abbreviation for Current Neurology and Neuroscience Reports?

Current Neurology and Neuroscience Reports’ NLM (PubMed) abbreviation is Curr Neurol Neurosci Rep.

What is the ISSN of Current Neurology and Neuroscience Reports?

The print ISSN is 1528-4042 and the online ISSN is 1534-6293.

What is the impact factor of Current Neurology and Neuroscience Reports?

Current Neurology and Neuroscience Reports’ Journal Impact Factor is 7.4 (2025), and its 5-year Impact Factor is 7.2, according to Springer Nature’s published metrics.

Is Current Neurology and Neuroscience Reports open access?

Current Neurology and Neuroscience Reports is a hybrid journal: most articles are published under the subscription model, and authors can choose to publish open access. From January 1 to November 19, 2026, 24 of 66 Current Neurology and Neuroscience Reports articles (36%) carry a Creative Commons license, per Crossref.

Current Neurology and Neuroscience Reports articles on DeepDyve are licensed from Springer Nature. Journal facts as of 21 November 2026.

Start reading Current Neurology and Neuroscience Reports today

One month free, then less than $2 a day. Current Neurology and Neuroscience Reports, plus millions of articles from thousands of journals.

Start free month

Like this: